1998

  • T. Mattern, C. Reich, U. Schönbeck, S. Ansorge, H.-U. Demuth, H. Loppnow, A. J. Ulmer, and H.-D. Flad: „CD26 (Dipeptidyl Peptidase IV) on Human T Lymphocytes does not Mediate Adhesion of these Cells to Endothelial Cells or Fibroblasts“ Immunobiology 198, 465-475 (1997/98)
  • F. P. Meyer, U. Tröger, S. Ansorge, A. Ittenson, U. Bank, F. Bühling, J. Läuter, and F.-W. Röhl: „‘Dominance’ Personality Trait and Immune System in Healthy Volunteers“ Human Psychopharmacol. 13, 183-189 (1998)
  • D. Reinhold, R.W. Vetter, K. Mnich, F. Bühling, U. Lendeckel, I. Born, J. Faust, K. Neubert, H. Gollnick, and S. Ansorge: „Dipeptidyl peptidase IV (DP IV, CD26) is involved in regulation of DNA synthesis in human keratinocytes“  FEBS Letters 428, 100-104 (1998)
  • D. Reinhold, B. Hemmer, B. Gran, I. Born, J. Faust, K. Neubert, H.F. McFarland, R. Martin, S. Ansorge: „Inhibitors of dipeptidyl peptidase IV/CD26 suppress activation of human MBP-specific CD4+ T cell clones“  J. Neuroimmunol. 87, 203-209 (1998)
  • Fengler, C. Mrestani-Klaus, D. Reinhold, S. Wrenger, S. Ansorge, J. Faust, K. Neubert, W. Brandt: „Determination of the Solution Conformation of HIV-1 Tat(1-9) Peptides by Means of Molecular Dynamics Simulations Considering NMR Data and Docking Studies into an Active Site Model of DP IV“ J. Mol. Model. 4, 200-210 (1998)
  • F.P. Meyer, U. Tröger, S. Ansorge, A. Ittenson, U. Bank, F. Bühling, J. Läuter, F.W. Röhl: „‘Dominance’ personality trait and immune system in healthy volunteers - Are they criteria for clinical trials?“ Clin. Pharmacol. 16, 25-32 (1998)
  • C. Mrestani-Klaus, A. Fengler, W. Brandt, J. Faust, S. Wrenger, D. Reinhold, S. Ansorge, and K. Neubert:„1H NMR Conformational Study on N-Terminal Nonapeptide Sequences of HIV-1 Tat Protein: A Contribution to Structure-Activity Relationships“ J. Peptide Science 4, 400-410 (1998)
  • T. Kähne, K. Neubert, J. Faust, and S. Ansorge: „Early Phosphorylation Events Induced by DP IV/CD26-Specific Inhibitors“ Cellular Immunology 189, 60-66 (1998)